![]() | ![]() |
Formats:
|
||||||||||||||||||
Copyright © 2008 The Author(s) Oxygen-dependent, alternative promoter controls translation of tco1+ in fission yeast Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA *To whom correspondence should be addressed. Phone: +1 443 287 5026, Fax: +1 410 955 4129, Email: peter.espenshade/at/jhmi.edu Received November 5, 2007; Revised January 15, 2008; Accepted January 16, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Eukaryotic cells respond to changes in environmental oxygen supply by increasing transcription and subsequent translation of gene products required for adaptation to low oxygen. In fission yeast, the ortholog of mammalian sterol regulatory element binding protein (SREBP), called Sre1, activates low-oxygen gene expression and is essential for anaerobic growth. Previous studies in multiple organisms indicate that SREBP transcription factors function as positive regulators of gene expression by increasing transcription. Here, we describe a unique mechanism by which activation of Sre1-dependent transcription downregulates protein expression under low oxygen. Paradoxically, Sre1 inhibits expression of tco1+ gene product by activating its transcription. Under low oxygen, Sre1 directs transcription of tco1+ from an alternate, upstream promoter and inhibits expression of the normoxic tco1+ transcript. The resulting low-oxygen transcript contains an additional 751 nt in the 5′ untranslated region that is predicted to form a stable, complex secondary structure. Interestingly, polysome profile experiments revealed that this new longer transcript is translationally silent, leading to a decrease in Tco1 protein expression under low oxygen. Together, these results describe a new mechanism for oxygen-dependent control of gene expression and provide an example of negative regulation of protein expression by an SREBP homolog. INTRODUCTION To survive in diverse environments, organisms have developed mechanisms to allow growth under conditions of limiting nutrients. For many organisms including fungi, oxygen is a critical nutrient and cells have evolved ways in which to adapt to a hypoxic environment. Changes in gene transcription and regulation of mRNA translation play a critical role in the response to hypoxia. In mammals, the hypoxia inducible factor (HIF) family of transcription factors are the principal regulators of hypoxic transcription (1). In addition, hypoxia regulates gene expression by suppressing protein synthesis through the inhibition of translation initiation (2,3). Both of these mechanisms combine to mediate an adaptive response to limiting oxygen supply in mammalian cells. In the fission yeast Schizosaccharomyces pombe, the transcriptional response to limiting oxygen is mediated by the membrane-bound transcription factor Sre1, the yeast homolog of the mammalian sterol regulatory element binding protein (SREBP) which regulates cellular cholesterol homeostasis (4). Sre1 (900 aa) contains two transmembrane segments and is inserted into the ER membrane in a hairpin orientation with the N- and C-termini in the cytosol (5). The N-terminus of Sre1 is a basic helix–loop–helix, leucine zipper transcription factor that binds to a DNA sequence called a Sre1 regulatory element (SRE) to activate transcription of adjacent genes (6). Under atmospheric oxygen conditions, Sre1 is inactive and remains sequestered in the ER membrane. Under low oxygen, Sre1 exits the ER and is proteolytically cleaved in a post-ER compartment to release the N-terminal transcription factor (Sre1N), which enters the nucleus and activates gene expression. Genome-wide mRNA expression analysis revealed that under low oxygen Sre1 is primarily a transcriptional activator. Sre1 induces expression of 115 genes and controls expression of 68% of genes upregulated >2-fold under low oxygen (6). Sre1 target genes include oxygen-dependent enzymes in lipid and heme biosynthesis as well as other gene products expected to be required for hypoxic growth. Consistent with these results, sre1+ is essential for growth under low oxygen conditions (5). Unlike mammals, regulation of translation by oxygen has not been reported in fission yeast. To date, Sre1 and SREBPs are believed to function by upregulating protein expression through increased gene transcription (4,7). In this study, we describe a unique mechanism for oxygen-dependent regulation of translation that requires Sre1. Unexpectedly, Sre1 inhibits protein expression by upregulating transcription of the target gene, tco1+. Under low oxygen, Sre1 directs transcription of tco1+ from an alternate, upstream promoter that results in a transcript with a longer 5′ untranslated region (UTR). Interestingly, this longer low-oxygen transcript is translationally silent, leading to a decrease in Tco1 protein expression under low oxygen. Collectively, these findings outline a new mechanism for oxygen-dependent control of translation and provide an example of negative regulation of protein expression by an SREBP homolog. MATERIALS AND METHODS Strains, plasmids and standard procedures Schizosaccharomyces pombe wild-type KGY425 (h−, his3-D1, leu1-32, ura4-D18, ade6-M210) and sre1Δ strains have been described previously (5,8). Materials, media and standard procedures including northern blotting, western blotting, chromatin immunoprecipitation and electrophoretic mobility shift assay have been described previously (5,6,9). Yeast deleted for tco1+/SPAC17G6.02c were generated by homologous recombination using standard techniques by replacing the tco1+ open reading frame with the kanamycin resistance gene (10). The tco1LΔ strain was created by replacing −1790 nt to −1250 nt upstream of tco1+ ORF with ura4+. A sre1N plasmid overexpressing sre1+ (1–1320 nt) from the thiamine repressible, nmt promoter was generated by inserting a PCR product into the SalI–BamHI sites of REP3× (11). The sre1N plasmid codes for Sre1(aa 1–440). Supplementary Table 1 contains sequences of oligonucleotides used. Mapping the ends of tco1+ mRNA cDNA was generated using Superscript II (Invitrogen) and an oligo dT primer from DNAse-treated RNA extracted from wild-type cells grown +/− oxygen for 6 h. 5′ and 3′ transcript ends were amplified using Gene Racer kit (Invitrogen). The 5′ and 3′ Rapid Amplification of cDNA Ends (RACE) products were cloned into TOPO-TA vector (Invitrogen) and sequenced. The tco1L 5′RACE product was sequenced by primer walking in three reactions. Five independent clones were sequenced for both culture conditions and the longest sequence shown by at least two clones was used. Tco1 antiserum An N-terminal GST-fusion to Tco1 (aa 263–324) in pGEX4T1 was expressed in Escherichia coli using standard techniques. Recombinant fusion protein was purified using glutathione-agarose beads (Sigma), dialyzed to remove excess glutathione, and used as antigen to generate antiserum (Covance). Polysome profiling Polysomes were isolated as described previously with minor modifications (12,13). Wild-type cells were grown in rich medium in the presence or absence of oxygen for 8 h, treated with 0.1 mg/ml cycloheximide and immediately placed on ice. Cells were centrifuged, washed in ice-cold lysis buffer (20 mM Tris–HCl pH 8.0, 140 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.1 mg/ml cycloheximide and 1 mg/ml heparin) and lysed with glass beads in 1 ml lysis buffer by vortexing eight times for 30 s with incubation on ice for 30 s between pulses. Following addition of 100 µl each of 10% Triton X-100 and 10% sodium deoxycholate, lysates were incubated on ice for 5 min with an additional vortex pulse of 30 s. Lysates were cleared and 25 A260nm units were layered onto a 11-ml 10–50% (w/v) sucrose gradient (containing 20 mM Tris–HCl pH 8.0, 140 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 0.1 mg/ml cycloheximide, 0.5 mg/ml heparin) and centrifuged at 35 000 r.p.m. in a SW41 rotor for 170 min at 4°C. Fractions (~950 μl) were collected using an ISCO collection system and adjusted to 0.05% SDS. Following addition of yeast tRNA (20 µg/ml) (Invitrogen) and luciferase RNA control (0.1 μg/ml) (Promega) to each fraction, RNA was precipitated overnight and purified using RNeasy mini columns (Qiagen). cDNA was synthesized from RNA using SuperScript First-Strand Synthesis System (Invitrogen). The cDNA was diluted and amplified using gene-specific oligos by quantitative PCR (Bio-Rad) using Sybr-Green (ABgene). The Ct values for the gene of interest were used to determine the normalized value for each fraction using the formula [2 (Ctluciferase–Cttarget gene)]. The relative RNA amount was calculated by dividing the amount in each fraction by the total signal in all fractions.Model for RNA structure The predicted secondary structures for tco1L (−1406 to −1 nt) and tco1S (−655 to −1 nt) 5′UTR was determined using the GeneBee RNA secondary structure prediction software (www.genebee.msu.su/services/rna2_full.html) (14). Default settings were used to derive the models shown in Figure 6
RESULTS Transcriptional profiling experiments of oxygen-dependent gene expression in S. pombe identified Sre1 target genes that were upregulated under low oxygen (6). These target genes functioned in diverse metabolic pathways such as the synthesis of heme, ergosterol, ubiquinone and sphingolipids. Additional expression profiling experiments identified an uncategorized Sre1 target gene SPAC17G6.02c, which was upregulated under low oxygen. SPAC17G6.02c codes for a 324-aa RTA1-like protein that is predicted to contain seven transmembrane domains. The Saccharomyces cerevisiae genome codes for four homologs of SPAC17G6.02c: RSB1, RTA1, RTM1 and an uncharacterized gene YER185W. Previous studies demonstrate that these S. cerevisiae genes are involved in efflux of different cytotoxic compounds, such as sphingoid long-chain bases by Rsb1p (15), 7-amino-cholesterol by Rta1p (16) and an unknown toxic substance in molasses by Rtm1p (17). Due to the potential function of SPAC17G6.02c in oxygen-regulated lipid transport, we characterized this gene further and based on our results we named it tco1+ for translation controlled by oxygen. To confirm that tco1+ is upregulated under low oxygen by Sre1, we performed northern analysis using a strand-specific probe on RNA isolated from cells grown in the presence or absence of oxygen for increasing time (Figure 1
The increase in tco1+ transcript length could result from differential splicing or changes in the length of the mRNA UTRs. Given that tco1+ contains no predicted introns, we used RACE to determine the sequences of the 5′ and 3′UTRs for each transcript. In the presence of oxygen, the tco1S 5′UTR was 655 nt and in the absence of oxygen the tco1L 5′UTR was 1406 nt (Figure 1 Thus far, the data are consistent with a model in which under low oxygen Sre1 directs transcription of tco1L from an anaerobic promoter upstream of the aerobic promoter that produces tco1S. To test whether Sre1 binds to the tco1+ promoter in vivo under low oxygen, we performed a chromatin immunoprecipitation experiment. Using primers positioned 100-bp upstream of the start of the tco1L transcript to detect DNA binding, Sre1 bound specifically to the tco1+ promoter and binding was increased 5-fold under low oxygen (Figure 2
The low oxygen increase in tco1L transcript is accompanied by a decrease in tco1S transcript. To investigate if synthesis of tco1L is required for decreased levels of tco1S, we deleted sequences upstream of tco1S predicted to contain the transcriptional start site and regulatory elements for tco1L. In this strain designated tco1LΔ, tco1L transcript was not expressed under low oxygen and tco1S transcript was still present after 10 h of growth under low oxygen (Figure 2 Sequence analysis predicted that both the tco1L and tco1S transcripts code for the same protein. To examine the translation products of these two transcripts, we raised antibodies to the C-terminus of Tco1, which is a predicted membrane protein. Microsomes were prepared from wild-type, sre1Δ and tco1Δ cells grown in presence or absence of oxygen for 6 h and these membranes were analyzed by immunoblotting for Tco1 (Figure 3
To test whether inhibition of Tco1 synthesis requires both activation of Sre1 and low oxygen, we overexpressed Sre1N in the presence of oxygen in wild-type cells. Cells carrying either empty vector or a plasmid expressing Sre1N from a thiamine repressible promoter were grown in the presence or absence of thiamine (18). Overexpression of Sre1N induced tco1L and inhibited expression of Tco1 even in the presence of oxygen (Figure 3 Next, we tested whether the inhibition of Tco1 expression by Sre1 is reversible. Sre1N has a short half-life of 5–10 min, and cleavage of Sre1 is rapidly inhibited upon shifting cells to the presence of oxygen (B.H. and P.E., unpublished data). Thus, Sre1N levels decrease rapidly after reintroducing oxygen to an anaerobic culture. For this experiment, we grew wild-type cells in the absence of oxygen for 10 h to induce tco1L and inhibit Tco1 expression (Figure 4
This oxygen-dependent regulation of Tco1 by Sre1 could result from the differential translation of tco1S and tco1L transcripts. To investigate this directly, we performed a polysome profiling experiment. Wild-type yeast were grown in the presence or absence of oxygen for 8 h to generate cells expressing either the tco1S or tco1L transcript, respectively. Cell lysates were fractionated on a sucrose gradient to separate ribosome-associated RNA from free RNA. Overall, there was no significant difference in the two polysome profiles, suggesting that translation efficiency was similar in the presence and absence of oxygen for 8 h (Figure 5
To examine the association of tco1L mRNA with ribosomes directly, we detected this transcript using primers directed to its unique 5′UTR. As expected, cells grown in the absence of oxygen had elevated levels of tco1L compared to cells grown in the presence of oxygen (Figure 5 RNA secondary structure can affect translation efficiency (19). In particular, stable stem-and-loop structures in the 5′UTR can inhibit translation initiation (20). To investigate whether the structure of the tco1+ mRNAs could contribute to their differential association with ribosomes, we used RNA structure programs to predict the secondary structure of the tco1L and tco1S 5′UTRs. Two different RNA structure programs (M-fold and GeneBee) predicted that the tco1L 5′UTR folds to form a highly structured, stable RNA (Figure 6 DISCUSSION In this study, we describe a unique mechanism for translational control by oxygen via the low oxygen transcription factor Sre1. Genome-wide expression analysis identified tco1+ as a Sre1 target gene of unknown function. Here, our characterization revealed that tco1+ mRNA is upregulated under low oxygen by Sre1 (Figure 1
Polysome profiling experiments demonstrated that tco1S, but not tco1L, is efficiently translated (Figure 5 One question that arises from these observations is why do cells make the tco1L transcript if it is not translated? One possible explanation is that inhibition of tco1S synthesis requires active transcription from the upstream tco1L promoter through a mechanism such as transcriptional interference or promoter competition (25,26). The regulated transcription of SER3 in S. cerevisiae is a well-characterized example of transcriptional interference in which the upstream, noncoding SRG1 transcript inhibits transcription from the SER3 promoter (27). In addition, the alcohol dehydrogenase gene in Drosophila melanogaster is regulated by two closely linked promoters during larval development. During late larval stages, there is a switch in promoter usage, wherein the distal promoter represses transcription from the proximal promoter by transcriptional interference (28). Here, transcription from the tco1L promoter inhibits transcription of tco1S (Figure 2 Finally, while our experiments do not directly address the physiological function of Tco1, we find that expression of Tco1 decreases under low oxygen due to a block in translation. tco1+ is a nonessential gene and we have failed to detect any phenotypes associated with the loss or overexpression of Tco1 under anaerobic or other standard laboratory conditions. By homology to the characterized S. cerevisiae transporters Rta1p, Rsb1p and Rtm1p, we speculate that Tco1 may export a toxic compound(s) from cells under aerobic conditions, but that this substrate is either absent or no longer toxic under anaerobic conditions. Future experiments will address the physiological basis for this unique mechanism for inhibition of Tco1 translation under low oxygen. SUPPLEMENTARY DATA Supplementary Data are available at NAR Online. ACKNOWLEDGEMENTS Predoctoral fellowship from the American Heart Association (0615376U to B.H.); National Institutes of Health (HL077588). P.E. is a recipient of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences. We thank Clara Bien, Ben Jilek, and Anuradha Gokhale for their excellent technical assistance and advice. In addition, we are grateful to Emerson Stewart for supplying recombinant Sre1 protein and members of the Espenshade for reviewing the manuscript. Funding to pay the Open Access publication charges for this article was provided by National Institutes of Health. Conflict of interest statement. None declared. REFERENCES 1. Semenza GL. Life with oxygen. Science. 2007;318:62–64. [PubMed] 2. Liu L, Simon MC. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 2004;3:492–497. [PubMed] 3. van den Beucken T, Koritzinsky M, Wouters BG. Translational control of gene expression during hypoxia. Cancer Biol. Ther. 2006;5:749–755. [PubMed] 4. Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 2007;41:401–427. [PubMed] 5. Hughes AL, Todd BL, Espenshade PJ. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell. 2005;120:831–842. [PubMed] 6. Todd BL, Stewart EV, Burg JS, Hughes AL, Espenshade PJ. Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast. Mol. Cell. Biol. 2006;26:2817–2831. [PubMed] 7. Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124:35–46. [PubMed] 8. Burke JD, Gould KL. Molecular cloning and characterization of the Schizosaccharomyces pombe his3 gene for use as a selectable marker. Mol. Gen. Genet. 1994;242:169–176. [PubMed] 9. Sehgal A, Lee CY, Espenshade PJ. SREBP controls oxygen-dependent mobilization of retrotransposons in fission yeast. PLoS. Genet. 2007;3:1389–1396. 10. Bahler J, Wu JQ, Longtine MS, Shah NG, McKenzie A., III, Steever AB, Wach A, Philippsen P, Pringle JR. Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast. 1998;14:943–951. [PubMed] 11. Forsburg SL. Comparison of Schizosaccharomyces pombe expression systems. Nucleic Acids Res. 1993;21:2955–2956. [PubMed] 12. Arava Y. Isolation of polysomal RNA for microarray analysis. Methods Mol. Biol. 2003;224:79–87. [PubMed] 13. MacKay VL, Li X, Flory MR, Turcott E, Law GL, Serikawa KA, Xu XL, Lee H, Goodlett DR, Aebersold R, et al. Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: response of yeast to mating pheromone. Mol. Cell Proteomics. 2004;3:478–489. [PubMed] 14. Brodskii LI, Ivanov VV, Kalaidzidis I, Leontovich AM, Nikolaev VK, Feranchuk SI, Drachev VA. GeneBee-NET: An Internet based server for biopolymer structure analysis. Biokhimiia. 1995;60:1221–1230. [PubMed] 15. Ogawa C, Kihara A, Gokoh M, Igarashi Y. Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J. Biol. Chem. 2003;278:1268–1272. [PubMed] 16. Soustre I, Letourneux Y, Karst F. Characterization of the Saccharomyces cerevisiae RTA1 gene involved in 7-aminocholesterol resistance. Curr. Genet. 1996;30:121–125. [PubMed] 17. Ness F, Aigle M. RTM1: a member of a new family of telomeric repeated genes in yeast. Genetics. 1995;140:945–956. [PubMed] 18. Maundrell K. nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J. Biol. Chem. 1990;265:10857–10864. [PubMed] 19. Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene. 2005;361:13–37. [PubMed] 20. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl Acad. Sci. USA. 1986;83:2850–2854. [PubMed] 21. Brenet F, Dussault N, Delfino C, Boudouresque F, Chinot O, Martin PM, Ouafik LH. Identification of secondary structure in the 5′-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation. Oncogene. 2006;25:6510–6519. [PubMed] 22. Vilela C, McCarthy JE. Regulation of fungal gene expression via short open reading frames in the mRNA 5′untranslated region. Mol. Microbiol. 2003;49:859–867. [PubMed] 23. Law GL, Bickel KS, MacKay VL, Morris DR. The undertranslated transcriptome reveals widespread translational silencing by alternative 5′ transcript leaders. Genome Biol. 2005;6:R111. [PubMed] 24. Wang Y, Newton DC, Robb GB, Kau CL, Miller TL, Cheung AH, Hall AV, VanDamme S, Wilcox JN, Marsden PA. RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc. Natl Acad. Sci. USA. 1999;96:12150–12155. [PubMed] 25. Shearwin KE, Callen BP, Egan JB. Transcriptional interference–a crash course. Trends Genet. 2005;21:339–345. [PubMed] 26. Mazo A, Hodgson JW, Petruk S, Sedkov Y, Brock HW. Transcriptional interference: an unexpected layer of complexity in gene regulation. J. Cell Sci. 2007;120:2755–2761. [PubMed] 27. Martens JA, Laprade L, Winston F. Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature. 2004;429:571–574. [PubMed] 28. Corbin V, Maniatis T. Role of transcriptional interference in the Drosophila melanogaster Adh promoter switch. Nature. 1989;337:279–282. [PubMed] 29. Lapeyre B, Michot B, Feliu J, Bachellerie JP. Nucleotide sequence of the Schizosaccharomyces pombe 25S ribosomal RNA and its phylogenetic implications. Nucleic Acids Res. 1993;21:3322. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||
Science. 2007 Oct 5; 318(5847):62-4.
[Science. 2007]Cancer Biol Ther. 2004 Jun; 3(6):492-7.
[Cancer Biol Ther. 2004]Cancer Biol Ther. 2006 Jul; 5(7):749-55.
[Cancer Biol Ther. 2006]Annu Rev Genet. 2007; 41():401-27.
[Annu Rev Genet. 2007]Cell. 2005 Mar 25; 120(6):831-42.
[Cell. 2005]Mol Cell Biol. 2006 Apr; 26(7):2817-31.
[Mol Cell Biol. 2006]Annu Rev Genet. 2007; 41():401-27.
[Annu Rev Genet. 2007]Cell. 2006 Jan 13; 124(1):35-46.
[Cell. 2006]Cell. 2005 Mar 25; 120(6):831-42.
[Cell. 2005]Mol Gen Genet. 1994 Jan; 242(2):169-76.
[Mol Gen Genet. 1994]Mol Cell Biol. 2006 Apr; 26(7):2817-31.
[Mol Cell Biol. 2006]Yeast. 1998 Jul; 14(10):943-51.
[Yeast. 1998]Nucleic Acids Res. 1993 Jun 25; 21(12):2955-6.
[Nucleic Acids Res. 1993]Methods Mol Biol. 2003; 224():79-87.
[Methods Mol Biol. 2003]Mol Cell Proteomics. 2004 May; 3(5):478-89.
[Mol Cell Proteomics. 2004]Biokhimiia. 1995 Aug; 60(8):1221-30.
[Biokhimiia. 1995]Mol Cell Biol. 2006 Apr; 26(7):2817-31.
[Mol Cell Biol. 2006]J Biol Chem. 2003 Jan 10; 278(2):1268-72.
[J Biol Chem. 2003]Curr Genet. 1996 Jul 31; 30(2):121-5.
[Curr Genet. 1996]Genetics. 1995 Jul; 140(3):945-56.
[Genetics. 1995]Nucleic Acids Res. 1993 Jul 11; 21(14):3322.
[Nucleic Acids Res. 1993]Nucleic Acids Res. 1993 Jul 11; 21(14):3322.
[Nucleic Acids Res. 1993]Mol Cell Biol. 2006 Apr; 26(7):2817-31.
[Mol Cell Biol. 2006]Mol Cell Biol. 2006 Apr; 26(7):2817-31.
[Mol Cell Biol. 2006]J Biol Chem. 1990 Jul 5; 265(19):10857-64.
[J Biol Chem. 1990]Gene. 2005 Nov 21; 361():13-37.
[Gene. 2005]Proc Natl Acad Sci U S A. 1986 May; 83(9):2850-4.
[Proc Natl Acad Sci U S A. 1986]Biokhimiia. 1995 Aug; 60(8):1221-30.
[Biokhimiia. 1995]Biokhimiia. 1995 Aug; 60(8):1221-30.
[Biokhimiia. 1995]Gene. 2005 Nov 21; 361():13-37.
[Gene. 2005]Proc Natl Acad Sci U S A. 1986 May; 83(9):2850-4.
[Proc Natl Acad Sci U S A. 1986]Oncogene. 2006 Oct 19; 25(49):6510-9.
[Oncogene. 2006]Mol Microbiol. 2003 Aug; 49(4):859-67.
[Mol Microbiol. 2003]Genome Biol. 2005; 6(13):R111.
[Genome Biol. 2005]Trends Genet. 2005 Jun; 21(6):339-45.
[Trends Genet. 2005]J Cell Sci. 2007 Aug 15; 120(Pt 16):2755-61.
[J Cell Sci. 2007]Nature. 2004 Jun 3; 429(6991):571-4.
[Nature. 2004]Nature. 1989 Jan 19; 337(6204):279-82.
[Nature. 1989]Genome Biol. 2005; 6(13):R111.
[Genome Biol. 2005]